tiprankstipranks
Advertisement
Advertisement

CATX Stock Latest News

3 High-Risk, High-Reward Stocks to Buy Now, According to Analysts
Market News3 High-Risk, High-Reward Stocks to Buy Now, According to Analysts
1d ago
CATX
GLOO
Perspective announces first patient dosed with (212Pb)VMT-alpha-NET
PremiumThe Fly
Perspective announces first patient dosed with (212Pb)VMT-alpha-NET
3d ago
CATX
Perspective Therapeutics Highlights Progress in Alpha Radiopharmaceutical Pipeline
PremiumCompany Announcements
Perspective Therapeutics Highlights Progress in Alpha Radiopharmaceutical Pipeline
5d ago
8K
CATX
Perspective Therapeutics shareholders approve directors and governance items
PremiumCompany Announcements
Perspective Therapeutics shareholders approve directors and governance items
9d ago
8K
CATX
Perspective Therapeutics Showcases Strong Interim Radiopharma Data
PremiumCompany Announcements
Perspective Therapeutics Showcases Strong Interim Radiopharma Data
15d ago
8K
CATX
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
19d ago
DE
HD
Perspective Therapeutics doses first patients in two Phase 1/2a studies
Premium
The Fly
Perspective Therapeutics doses first patients in two Phase 1/2a studies
19d ago
CATX
CATX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CATX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
20d ago
CATX
Perspective Therapeutics price target lowered to $6 from $7 at BofA
PremiumThe Fly
Perspective Therapeutics price target lowered to $6 from $7 at BofA
25d ago
CATX
Perspective Therapeutics reports Q1 EPS (25c), consensus (30c)
PremiumThe Fly
Perspective Therapeutics reports Q1 EPS (25c), consensus (30c)
25d ago
CATX
Perspective Therapeutics Highlights Q1 Progress and Strengthened Finances
PremiumCompany Announcements
Perspective Therapeutics Highlights Q1 Progress and Strengthened Finances
25d ago
8K
CATX
Perspective Therapeutics Highlights Alpha-Targeted Oncology Strategy Update
PremiumCompany Announcements
Perspective Therapeutics Highlights Alpha-Targeted Oncology Strategy Update
1M ago
8K
CATX
Perspective Therapeutics Highlights Encouraging Interim Neuroendocrine Tumor Data
PremiumCompany AnnouncementsPerspective Therapeutics Highlights Encouraging Interim Neuroendocrine Tumor Data
2M ago
8K
CATX
Perspective reports results from Phase 1/2a clinical trial of (212Pb)VMT-alpha-NET
Premium
The Fly
Perspective reports results from Phase 1/2a clinical trial of (212Pb)VMT-alpha-NET
2M ago
CATX
Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline
Premium
Company Announcements
Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline
2M ago
8K
CATX
Reiterating Buy on Perspective Therapeutics: Strong Cash Runway, Improving Earnings Outlook, and Clinical Milestones Support $13 DCF Valuation
PremiumRatings
Reiterating Buy on Perspective Therapeutics: Strong Cash Runway, Improving Earnings Outlook, and Clinical Milestones Support $13 DCF Valuation
2M ago
CATX
Perspective Therapeutics price target raised to $13 from $12 at H.C. Wainwright
PremiumThe Fly
Perspective Therapeutics price target raised to $13 from $12 at H.C. Wainwright
2M ago
CATX
Perspective Therapeutics price target raised to $8 from $7 at UBS
PremiumThe Fly
Perspective Therapeutics price target raised to $8 from $7 at UBS
3M ago
CATX
Perspective Therapeutics price target raised to $13 from $11 at B. Riley
PremiumThe Fly
Perspective Therapeutics price target raised to $13 from $11 at B. Riley
3M ago
CATX
Perspective Therapeutics price target raised to $8 from $7 at UBS
PremiumThe FlyPerspective Therapeutics price target raised to $8 from $7 at UBS
3M ago
CATX
Perspective Therapeutics Reports 2025 Results, Highlights Pipeline Progress
Premium
Company Announcements
Perspective Therapeutics Reports 2025 Results, Highlights Pipeline Progress
3M ago
8K
CATX
Perspective Therapeutics initiated with an Overweight at Piper Sandler
Premium
The Fly
Perspective Therapeutics initiated with an Overweight at Piper Sandler
4M ago
CATX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >